NI-1201

Indicaton

IL6-driven Inflammation

Therapeutic indications

You may also be interested in

AUP-16 (AUP1602-C)

AUP-16 is a multi-therapy live bacterial vector for chronic wounds: Diabetic Foot, Leg & Pressure Ulcers

Phase II started

Veblocema (infliximab SC)

Multiple indications in rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis and psoriasis

Marketed

Remsima (infliximab IV)

Multiple indications in rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis and psoriasis

Marketed